CYP24A1 and ovarian carcinoma: Numerous studies have suggested the expression level of the CYP24A1 was abnormally increased in several cancers, such as breast cancer, ovarian cancer, cervix carcinoma, lung cancer, and colon cancer [7, 37, 38].